Day: April 21, 2025

TEL AVIV, Israel, April 21, 2025 (GLOBE NEWSWIRE) — ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace company focused on safety systems for commercial unmanned aerial systems and counter UAS systems, announced today that official marketing approval from the Israeli Ministry of Defense’s Defense Export Controls Agency (DECA) was received for the DropAir™ Precision Airdrop System, developed in collaboration with Heven Drones (“Heven”) , a leading U.S. drone manufacturer with roots in Israel that specializes in custom autonomous UAV platforms.This authorization from DECA enables ParaZero and Heven to actively market their joint DropAir-integrated solution to global clients across commercial, defense, and humanitarian sectors. “Receiving DECA approval for our DropAir system and Heven integration...

Vagal Neuromodulation Offers a Novel Approach to Treating Type 2 Diabetes and Hypoglycemia Patent Enables Equivalent Efficacy with 10 times Lower Energy Consumption Than Current Device Fully Compatible with Standard Implantable Pulse Generators, Enabling Cost-Effective Development IRVINE, Calif., April 21, 2025 (GLOBE NEWSWIRE) — ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the Company has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for patent application 18/069,689, entitled, “High-Frequency Low Duty Cycle Patterns for Neural Regulation.” When issued, the patent will provide protection until August 4, 2037. The Diabetes Neuromodulation system leverages its proprietary vagus nerve block (vBloc™)...

OREM, Utah, April 21, 2025 (GLOBE NEWSWIRE) — Reflect Scientific Inc. (symbol: RSCF), a leading innovator in advanced refrigeration and cooling technologies, today announced significant financial improvements resulting from strategic market transitions and comprehensive cost-saving initiatives. Reflect Scientific’s recent move from the OTCQB market to the OTC Pink market has already generated over $100,000 in annual savings. Maintaining rigorous financial reporting standards, Reflect Scientific provides detailed and transparent financials despite the reduced regulatory expenses associated with the transition. Furthermore, the Company is set to transition to the OTCIQ market on July 1, 2025, anticipating further operational efficiencies. Additionally, Reflect Scientific is implementing operational cost-saving measures that...

CULVER CITY, Calif., April 21, 2025 (GLOBE NEWSWIRE) — Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital entertainment, announced that its wholly owned subsidiary, Interactive Films LLC (“Interactive Films”), has signed a Memorandum of Understanding (MOU) with Mega Matrix Inc. (NYSE American: MPU). Under this MOU, both parties will leverage their respective strengths to establish a comprehensive collaboration framework for the joint development, production, and global distribution of short dramas, further enhancing their presence in the entertainment industry. Mr. Hai Shi, Chairman and Co-CEO of Snail Games, commented, “Today’s announcement represents a strategic step forward in advancing Interactive Films’ short-drama business line and expanding...

Highly promising survival data from OVATION 2 Study of treatment of newly diagnosed advanced ovarian cancer to be presented  Initiation of Phase 3 trial sites underway for pivotal study of IMNN-001 following alignment on protocol with FDA LAWRENCEVILLE, N.J., April 21, 2025 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that an abstract highlighting new, highly encouraging, Overall Survival data from the Phase 2 OVATION 2 Study of IMNN-001 to treat women with newly diagnosed advanced ovarian cancer was accepted for oral presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. The meeting is being held May 30 – June 3, 2025, in Chicago, Illinois and virtually. IMUNON recently announced alignment...

Dragonfly Energy’s collaboration with the National Forest Foundation underscores the company’s continued commitment to sustainability and environmental stewardship. The pledge from Dragonfly Energy to plant thousands of trees is part of a bigger environmental plan initiated by the US Forest Service to combat climate change. Dragonfly Energy is committed to helping the National Forest Foundation reach its goal to successfully plant 50 million trees by the end of 2025.RENO, Nev., April 21, 2025 (GLOBE NEWSWIRE) — Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an industry leader in green energy storage and maker of Battle Born Batteries®, in recognition of Earth Day, is pledging to plant thousands of trees through a collaboration with the National Forest Foundation (NFF), the official non-profit...

TORONTO, April 21, 2025 (GLOBE NEWSWIRE) — BULGOLD Inc. (TSXV: ZLTO) (the “Company” or “BULGOLD”) is pleased to announce that it has filed its audited annual financial statements and MD&A for the year ended December 31, 2024. For the year ending December 31, 2024, the company incurred a net comprehensive loss of $642,831 ($0.02 per share). On December 31, 2024, the company had cash (and cash equivalents) of $345,204. About BULGOLD Inc. BULGOLD is a gold exploration company focused on the exploration and development of mineral exploration projects in Central and Eastern Europe. The Company controls 100% of three quality quartz-adularia epithermal gold projects located in the Bulgarian and Slovak portions of the Western Tethyan Belt: the Lutila Gold Project, the Kostilkovo Gold Project and the Kutel Gold Project. Management...

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer’s disease, Parkinson’s disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced that Marwan Noel Sabbagh, MD, Professor of Neurology at Barrow Neurological Institute and Chairman of Anavex’s Scientific Advisory Board gave an oral presentation titled, “Oral Blarcamesine Novel Mechanism for Alzheimer Disease: Autophagy Restoration through Upstream SIGMAR1 Activation Clinical Efficacy Phase IIb/III Trial” at the 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle...